Cargando…
Infections After High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
Infection represents an important cause of morbidity after autologous hematopoietic stem cell transplantation (HSCT). Immunodeficiency is the key risk factor and results from interplay between the underlying disease and its therapy. Various defects in the immune system coexist in HSCT recipients. In...
Autores principales: | Nucci, Marcio, Anaissie, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121020/ http://dx.doi.org/10.1007/978-3-662-44000-1_4 |
Ejemplares similares
-
Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas
por: Duarte, Bruno Kosa Lino, et al.
Publicado: (2011) -
SS-4 High dose chemotherapy with autologous hematopoietic stem cell transplantation for CNS lymphoma
por: Kondo, Eisei
Publicado: (2020) -
Prevention of Infections in Patients with Hematological Malignancies
por: Nucci, Marcio, et al.
Publicado: (2017) -
Herpes zoster after autologous hematopoietic stem cell transplantation
por: Santos, Kelli Borges dos, et al.
Publicado: (2016) -
Associations of Ficolins With Hematological Malignancies in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantations
por: Świerzko, Anna S., et al.
Publicado: (2020)